Inquiry Basket
Loading ......
Filter By Product Search for
RIT2
RIT2 Full Name
Ras-like without CAAX 2
RIT2 Introduction
RIT2 (Ras-like without CAAX 2), also referred to as Rin, is a small GTPase belonging to the Ras superfamily that is distinguished by its unusually high expression in neurons. Its name derives from a defining biochemical feature: unlike classical Ras proteins, RIT2 lacks the C-terminal CAAX motif that normally directs farnesylation and permanent membrane anchoring, so the protein instead cycles between the cytosol and specific membrane compartments through alternative signals. RIT2 participates in intracellular signaling cascades that support neuronal differentiation, neurite outgrowth, and the survival of dopaminergic neurons, and it has been linked to the function of the dopamine transporter, which controls the reuptake of dopamine at synapses. Interest in RIT2 intensified when genome-wide association studies identified common variants near the RIT2 locus as risk factors for Parkinson's disease, one of the most common neurodegenerative movement disorders. Subsequent work has examined how these variants alter RIT2 expression and dopamine handling, positioning RIT2 as a bridge between basic GTPase biology and the pathogenesis of Parkinson's disease. The related protein RIT1 shares many features with RIT2 but shows broader tissue distribution, underscoring the neuronal specialization of RIT2.
Figure 1. Model of RIT2 activity in directing autophagic flux. (Gao A Y L, Montagna D R, Hirst W D, et al. 2024)
GTPase Cycle and Molecular Features
The RIT2 protein adopts the canonical Ras fold, with conserved G1-G5 motifs that coordinate guanine nucleotide binding and catalyze GTP hydrolysis.
Its guanine nucleotide-binding (G) domain is flanked by N- and C-terminal extensions, and the absence of a CAAX box means that membrane association depends on polybasic sequences and regulated protein-lipid or protein-protein interactions rather than prenylation.
Like other Ras-family GTPases, RIT2 is thought to cycle between an active GTP-bound state and an inactive GDP-bound state, although the full complement of guanine nucleotide exchange factors and GTPase-activating proteins acting on RIT2 is only partially defined.
Effector engagement occurs through the switch I and switch II regions, which change conformation upon GTP binding and recruit downstream partners that couple RIT2 to cytoskeletal dynamics and vesicular traffic.
The RIT2 gene maps to human chromosome 18, and alternative splicing generates transcript variants with distinct expression profiles in the brain.
Within neurons, RIT2 is enriched in dopaminergic cell populations, including those of the substantia nigra, and localizes to regions of active signaling such as growth cones and synaptic compartments.
Neuronal Function, Dopamine Handling, and Parkinson's Disease
Functional studies implicate RIT2 in the signaling pathways by which neurotrophic factors and neuronal activity promote process outgrowth and synaptic connectivity, consistent with its high expression in developing and adult neurons.
A particularly well-studied function is the regulation of the dopamine transporter: RIT2 influences the trafficking, cell-surface expression, and reuptake activity of DAT, thereby tuning dopaminergic neurotransmission.
Given that dopaminergic neurons of the substantia nigra degenerate in Parkinson's disease, even modest changes in dopamine handling imposed by RIT2 variants are of considerable pathophysiological interest.
Genome-wide association studies in multiple populations have reproducibly associated the RIT2 locus with Parkinson's disease risk, and imaging studies suggest that risk genotypes are accompanied by alterations in dopamine transporter availability in the human brain.
Experimental manipulation of RIT2 in cell and animal models alters dopamine uptake and neuronal vulnerability to stressors relevant to neurodegeneration.
Together, these observations define RIT2 as a modulator of dopamine neuron function whose dysregulation contributes to the molecular underpinnings of Parkinson's disease, and as a potential target for disease-modifying strategies.
Alternate Names for RIT2
RIT2; Ras-like without CAAX 2; Ric (Drosophila) like, expressed in neurons; RIN; GTP-binding protein Rit2; RIBA; GTP-binding protein Roc2; Ric-like, expressed in neurons; ras-like without CAAX protein 2; ras-like protein expressed in neurons; RIN; ROC2;
Loading ......
